These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30354221)

  • 1. Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.
    Wong YK; Cheung CYY; Tang CS; Au KW; Hai JSH; Lee CH; Lau KK; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2519-2527. PubMed ID: 30354221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography.
    Cheng JM; Akkerhuis KM; Meilhac O; Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Piquer D; Merle D; du Paty E; Galéa P; Jaisser F; Rossignol P; Serruys PW; Boersma E; Fareh J; Kardys I
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1078-84. PubMed ID: 24651681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil gelatinase-associated lipocalin (NGAL) and cardiovascular events in patients with stable coronary artery disease.
    Sivalingam Z; Erik Magnusson N; Grove EL; Hvas AM; Dalby Kristensen S; Bøjet Larsen S
    Scand J Clin Lab Invest; 2018 Oct; 78(6):470-476. PubMed ID: 30261750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.
    Tuñón J; Fernández-Fernández B; Carda R; Pello AM; Cristóbal C; Tarín N; Aceña Á; González-Casaus ML; Huelmos A; Alonso J; Lorenzo Ó; González-Parra E; Hernández-González I; Mahíllo-Fernández I; López-Bescós L; Egido J
    Diabetes Metab Res Rev; 2016 Oct; 32(7):685-693. PubMed ID: 26888181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study.
    Chow WS; Tso AW; Xu A; Yuen MM; Fong CH; Lam TH; Lo SV; Tse HF; Woo YC; Yeung CY; Cheung BM; Lam KS
    J Am Heart Assoc; 2013 Jan; 2(1):e004176. PubMed ID: 23525430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification.
    Gan F; Huang J; Dai T; Li M; Liu J
    Ann Palliat Med; 2020 Mar; 9(2):368-374. PubMed ID: 32268770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention.
    Takagi W; Miyoshi T; Doi M; Okawa K; Nosaka K; Nishibe T; Matsuo N; Hirohata S; Ito H
    BMC Cardiovasc Disord; 2017 Oct; 17(1):258. PubMed ID: 29017449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Levels of Serum Adipocyte Fatty Acid-binding Protein Predict Cardiovascular Events in Coronary Artery Disease Patients.
    Huang IC; Hsu BG; Chang CC; Lee CJ; Wang JH
    Int J Med Sci; 2018; 15(12):1268-1274. PubMed ID: 30275752
    [No Abstract]   [Full Text] [Related]  

  • 10. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
    Alderson HV; Ritchie JP; Middleton R; Larsson A; Larsson TE; Kalra PA
    Nephrology (Carlton); 2016 Jul; 21(7):566-73. PubMed ID: 27334353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.
    Aceña A; Franco-Peláez JA; Gutierrez-Landaluce C; Pello AM; Cristóbal C; Tarín N; Huelmos A; Carda R; Martín-Mariscal ML; Alonso J; González-Parra E; González-Casaus ML; Lorenzo Ó; López Bescos L; Egido J; Tuñón J
    Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):762-767. PubMed ID: 28803689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.
    Tso AW; Xu A; Sham PC; Wat NM; Wang Y; Fong CH; Cheung BM; Janus ED; Lam KS
    Diabetes Care; 2007 Oct; 30(10):2667-72. PubMed ID: 17620449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease.
    Li M; Duan L; Cai YL; Li HY; Hao BC; Chen JQ; Liu HB
    Cardiovasc Diabetol; 2020 Aug; 19(1):120. PubMed ID: 32746821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio.
    Jin J; Peng DQ; Yuan SG; Zhao SP; Ning XH; Wang SH; Li SL
    Clin Chim Acta; 2010 Nov; 411(21-22):1761-5. PubMed ID: 20688054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Chan YH; Hai JSH; Lau KK; Tse HF
    Cardiovasc Diabetol; 2021 Apr; 20(1):88. PubMed ID: 33894788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
    Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study).
    McCarthy CP; van Kimmenade RRJ; Gaggin HK; Simon ML; Ibrahim NE; Gandhi P; Kelly N; Motiwala SR; Belcher AM; Harisiades J; Magaret CA; Rhyne RF; Januzzi JL
    Am J Cardiol; 2017 Jul; 120(1):25-32. PubMed ID: 28487034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study.
    Zhang HW; Jin JL; Cao YX; Liu HH; Zhang Y; Guo YL; Wu NQ; Gao Y; Xu RX; Hua Q; Li YF; Cui CJ; Liu G; Dong Q; Sun J; Li JJ
    Cardiovasc Diabetol; 2020 Feb; 19(1):15. PubMed ID: 32041617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.